![](/img/cover-not-exists.png)
Intravenous and oral ibandronate have better safety and tolerability profiles than zoledronic acid: Evidence from comparative phase III trials
B. Bergström, M. Lichinitser, J.J. BodyVolume:
38
Year:
2006
Language:
english
Pages:
70
DOI:
10.1016/j.bone.2006.01.012
File:
PDF, 62 KB
english, 2006